PMC:7077337 / 6363-6592 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"211","span":{"begin":151,"end":159},"obj":"Species"},{"id":"226","span":{"begin":10,"end":17},"obj":"Disease"},{"id":"227","span":{"begin":62,"end":70},"obj":"Disease"},{"id":"228","span":{"begin":117,"end":136},"obj":"Disease"},{"id":"229","span":{"begin":180,"end":215},"obj":"Disease"},{"id":"230","span":{"begin":217,"end":221},"obj":"Disease"}],"attributes":[{"id":"A211","pred":"tao:has_database_id","subj":"211","obj":"Tax:9606"},{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"MESH:D063806"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"MESH:D006261"},{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"MESH:C000657245"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"MESH:D012128"},{"id":"A230","pred":"tao:has_database_id","subj":"230","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"atigue or myalgia (18, 44%), sputum production (11, 28%), and headache (3, 8%) [10]. Among these 41 initial cases of 2019-nCoV infection there were 12 patients (32%) who developed acute respiratory distress syndrome (ARDS), 13 (3"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":29,"end":35},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma312401"}],"text":"atigue or myalgia (18, 44%), sputum production (11, 28%), and headache (3, 8%) [10]. Among these 41 initial cases of 2019-nCoV infection there were 12 patients (32%) who developed acute respiratory distress syndrome (ARDS), 13 (3"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":29,"end":35},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0007311"}],"text":"atigue or myalgia (18, 44%), sputum production (11, 28%), and headache (3, 8%) [10]. Among these 41 initial cases of 2019-nCoV infection there were 12 patients (32%) who developed acute respiratory distress syndrome (ARDS), 13 (3"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T45","span":{"begin":117,"end":136},"obj":"Disease"},{"id":"T46","span":{"begin":127,"end":136},"obj":"Disease"},{"id":"T47","span":{"begin":180,"end":215},"obj":"Disease"},{"id":"T48","span":{"begin":186,"end":215},"obj":"Disease"},{"id":"T49","span":{"begin":217,"end":221},"obj":"Disease"}],"attributes":[{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"atigue or myalgia (18, 44%), sputum production (11, 28%), and headache (3, 8%) [10]. Among these 41 initial cases of 2019-nCoV infection there were 12 patients (32%) who developed acute respiratory distress syndrome (ARDS), 13 (3"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T36","span":{"begin":19,"end":21},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T37","span":{"begin":48,"end":50},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T38","span":{"begin":97,"end":99},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"}],"text":"atigue or myalgia (18, 44%), sputum production (11, 28%), and headache (3, 8%) [10]. Among these 41 initial cases of 2019-nCoV infection there were 12 patients (32%) who developed acute respiratory distress syndrome (ARDS), 13 (3"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T14","span":{"begin":10,"end":17},"obj":"Phenotype"},{"id":"T15","span":{"begin":62,"end":70},"obj":"Phenotype"},{"id":"T16","span":{"begin":186,"end":206},"obj":"Phenotype"}],"attributes":[{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0003326"},{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0002315"},{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"atigue or myalgia (18, 44%), sputum production (11, 28%), and headache (3, 8%) [10]. Among these 41 initial cases of 2019-nCoV infection there were 12 patients (32%) who developed acute respiratory distress syndrome (ARDS), 13 (3"}